Trial Information
Thromboembolic Complications Related to Asparaginase in Children With ALL Treated According to NOPHO ALL 2008
Inclusion Criteria:
- Acute lymphoblastic leukaemia,
- Age 1 year to 16 years old,
- Central line,
- Protocol NOPHO ALL 2008.
Exclusion Criteria:
- Refusal of participation,
- Treated according to protocol other than NOPHO ALL 2008.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Clinical evident thrombosis
Outcome Time Frame:
33 weeks
Safety Issue:
No
Principal Investigator
Ellen Ruud, MD PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Oslo University Hospital
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
ASP NOPHO 2008
NCT ID:
NCT00982514
Start Date:
September 2009
Completion Date:
December 2014
Related Keywords:
- Thromboembolism
- Acute Lymphoblastic Leukemia
- Asparaginase
- thrombosis
- ALL
- central line
- Leukemia
- Leukemia, Lymphoid
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Thromboembolism